Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
This study is ongoing, but not recruiting participants.
Study NCT00006055 Information provided by Office of Rare Diseases (ORD)
First Received: July 5, 2000 Last Updated: June 23, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Purpura, Schoenlein-Henoch
Graft Versus Host Disease
Anemia, Hemolytic, Autoimmune
Rheumatoid Arthritis
Churg-Strauss Syndrome
Hypersensitivity Vasculitis
Wegener's Granulomatosis
Systemic Lupus Erythematosus
Giant Cell Arteritis
Pure Red Cell Aplasia
Juvenile Rheumatoid Arthritis
Polyarteritis Nodosa
Autoimmune Thrombocytopenic Purpura
Takayasu Arteritis
Additional conditions recognized in this trial
Anemia
Anemia, Hemolytic
Aortic Arch Syndromes
Arteritis
Arthritis
Arthritis, Juvenile Rheumatoid
Arthritis, Rheumatoid
Graft vs Host Disease
Hypersensitivity
Lupus Erythematosus, Systemic
Polymyalgia Rheumatica
Purpura
Purpura, Thrombocytopenic
Purpura, Thrombocytopenic, Idiopathic
Red-Cell Aplasia, Pure
Syndrome
Vasculitis
Vasculitis, Hypersensitivity
Wegener Granulomatosis
More general conditions related to this trial
Aortic Diseases
Autoimmune Diseases
Autoimmune Diseases of the Nervous System
Blood Coagulation Disorders
Blood Platelet Disorders
Brain Diseases
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Connective Tissue Diseases
Disease
Granuloma
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune Complex Diseases
Immune System Diseases
Joint Diseases
Kidney Diseases
Lung Diseases
Lung Diseases, Interstitial
Lymphatic Diseases
Lymphoproliferative Disorders
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Pathologic Processes
Respiratory Tract Diseases
Rheumatic Diseases
Signs and Symptoms
Skin Diseases
Skin Diseases, Vascular
Skin Manifestations
Thrombocytopenia
Urologic Diseases
Vascular Diseases
Vasculitis, Central Nervous System
Interventions listed in this trial
anti-thymocyte globulin
cyclophosphamide
cyclosporine
filgrastim
methylprednisolone
prednisone
Additional drug interventions recognized in this trial
Antilymphocyte Serum
Cyclosporins
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
More general drug interventions related to this trial
Alkylating Agents
Anti-Infective Agents
Anti-Inflammatory Agents
Antiemetics
Antifungal Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Hormonal
Antirheumatic Agents
Autonomic Agents
Central Nervous System Agents
Dermatologic Agents
Enzyme Inhibitors
Gastrointestinal Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Neuroprotective Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Fairview University Medical Center
Back to top of Main Content
